SCHEMBL4249546

SCHEMBL4249546

NS(=O)(=O)CCCc1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.56
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 4/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
POLB P06746 1/20 0.46
HRH3 Q9Y5N1 2/20 0.44
HRH4 Q9H3N8 1/20 0.44
NAAA Q02083 1/20 0.44
TAAR1 Q96RJ0 1/20 0.43
ALOX15 P16050 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184428 0.89 HRH1 (0.57) HRH1LMNACYP1A2TDP1ALDH1A1
Potassium SCHEMBL4063307 0.87 HRH1 (0.55) HRH1LMNACYP1A2TDP1ALDH1A1
SCHEMBL4063300 0.87 HRH1 (0.55) HRH1LMNACYP1A2TDP1ALDH1A1
SCHEMBL7249187 0.86 HRH1 (0.53) HRH1LMNACYP1A2CYP2C19SMN1; SMN2
SCHEMBL865443 0.82 LMNA (0.57) HRH1LMNACYP1A2CYP2C19SMN1; SMN2
Water SCHEMBL27667215 0.82 LMNA (0.57) HRH1LMNACYP1A2CYP2C19SMN1; SMN2
SCHEMBL1273199 0.82 LMNA (0.57) HRH1LMNACYP1A2CYP2C19SMN1; SMN2
SCHEMBL1273198 0.82 HRH1 (0.51) HRH1LMNACYP1A2CYP2C19SMN1; SMN2
SCHEMBL28982964 0.81 LMNA (0.55) HRH1LMNACYP1A2CYP2C19SMN1; SMN2
Ammonia Solution, Strong SCHEMBL28869767 0.81 LMNA (0.55) HRH1LMNACYP1A2CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049494-A2 TYROSINE KINASE INHIBITORS Merck & Co., Inc. (US) 2009-04-22 EP claimed
WO-2008008310-A2 TYROSINE KINASE INHIBITORS MERCK & CO., INC. (US) 2008-01-17 WO claimed
EP-3541792-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR Amgen Inc. (US) 2019-09-25 EP disclosed
WO-2018097944-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-05-31 WO disclosed
EP-2049494-A2 TYROSINE KINASE INHIBITORS Merck & Co., Inc. (US) 2009-04-22 EP disclosed
WO-2008008310-A2 TYROSINE KINASE INHIBITORS MERCK & CO., INC. (US) 2008-01-17 WO disclosed